PATH | VRL
Menu

Find resources

Total results with these characteristics: 1794

Page 89 of 90
WHO Best Practices for Injections and Related Procedures Toolkit

This toolkit covers elements of standard precautions relevant to the transmission of bloodborne pathogens through unsafe injection practices in health-care settings. It aims to help to increase health workers’ awareness of the importance of …

Author: World Health Organization, Safe Injection Global Network

Publication date: 2010

WHO Brighton Collaboration on Maternal Immunization Meeting Report

This report summarizes a consultation meeting held jointly by the World Health Organization's Initiative for Vaccine Research and the Brighton Collaboration in Geneva, Switzerland, from July 24 to 25, 2014 to facilitate harmonization of key events …

Author: World Health Organization

Publication date: 2014

WHO Cervical Cancer Prevention and Control Costing (C4P) Tool User Guide

The World Health Organization has developed a generic costing and planning tool for cervical cancer prevention and control to help program planners and managers generate annual cost projections over a five-year period to scale-up human …

Author: World Health Organization

Publication date: 2012

WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016

This article, published in Vaccine, reports the outcome of a World Health Organization technical consultation that considered development pathways for group B Streptococcus (GBS) vaccines. The meeting discussed numerous topics, including disease …

Author: Kobayashi M, Schrag SJ, Alderson MR, et al.

Publication date: 2016

WHO Consultation on Respiratory Syncytial Virus Vaccine Development Report From a World Health Organization Meeting Held on 23–24 March 2015

This article, published in Vaccine, summarizes a World Health Organization-convened respiratory syncytial virus (RSV) vaccine consultation held on March 23 and 24, 2015 in Geneva, Switzerland, which brought together experts from around the world to …

Author: Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, the WHO RSV Vaccine Consultation Expert Group

Publication date: 2015

WHO Expert Consultation on Serotype Composition of Pneumococcal Conjugate Vaccines for Use in Resource-Poor Developing Countries, 26–27 October 2006, Geneva.

Published in the journal Vaccine, this article reports on a World Health Organization expert consultation to formulate a data-driven approach to determine the minimum or optimal formulation of pneumococcal conjugate vaccines, particularly keeping in …

Author: Cherian T

Publication date: 2007

WHO Global Action Plan to Minimize Poliovirus Facility-Associated Risk After Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of Oral Polio Vaccine Use

This is the third edition of the Global Action Plan for eradicating polio. It includes suggested guidelines for the safe handling and containment of poliovirus infectious and potentially infectious materials, with the goal of reduced risk of …

Author: World Health Organization

Publication date: 2015

WHO Guidance Note: Vaccine Diluents, Revision 2015

This guidance note explains the proper handling and use of vaccine diluents, including critical steps for reconstituting vaccines safely and the appropriate storage and stock management procedures. This document is designed to be used in conjunction …

Author: World Health Organization

Publication date: 2015

WHO HPV Laboratory Network

The mission of the World Health Organization (WHO) global human papillomavirus (HPV) Laboratory Network (LabNet) is to contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, …

Author: World Health Organization

WHO Human Papillomavirus Vaccine Programmatic Resources

This web page provides links to further resources related to human papillomavirus vaccines. Topics include policy and decision making, implementation, and monitoring and surveillance.

Author: World Health Organization

WHO Initiative to Increase Global and Equitable Access to Influenza Vaccine in the Event of a Pandemic: Supporting Developing Country Production Capacity Through Technology Transfer

This article, published in Vaccine, showcases the interim results of the World Health Organization's technology transfer initiative to increase global and equitable access to influenza vaccine in the event of a pandemic. It highlights the progress …

Author: Friede M, Palkonyay L, Alfonso C, et al.

Publication date: 2011

WHO Policy Development Processes for a New Vaccine: Case Study of Malaria Vaccines

This article, published in Malaria Journal, analyzed the World Health Organization policy development process to predict its course for a malaria vaccine. Data needs for a malaria vaccine include safety; the demonstration of efficacy in a range of …

Author: Milstien J, Cardenas V, Cheyne J, Brooks A

Publication date: 2010

WHO Policy Statement: Multi-dose Vial Policy (MDVP) - Handling of Multi-dose Vaccine Vials After Opening

This document is designed to provide guidance to national and senior-level program managers on the proper handling of multi-dose vaccine vials once opened. It presents the World Health Organization’s official position on this issue, including the …

Author: World Health Organization

Publication date: 2014

WHO Preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines

This report provides guidance on vaccine development strategies and targets for RSV vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target population, …

Author: World Health Organization

Publication date: 2017

WHO Preferred Product Characteristics (PPC) for Malaria Vaccines

This document provides guidance for vaccine manufacturers and funding agencies in refining their product development plans for malaria vaccines. It clarifies the World Health Organization's preferences with regard to many criteria that form part of …

Author: World Health Organization

Publication date: 2014

WHO Prequalified Vaccines

This web page provides a database of vaccines prequalified by the World Health Organization which allows the user to search by manufacturer, vaccine, or country of manufacture. The database is tailored to support immunization program managers, …

Author: World Health Organization

WHO Recommendations for Routine Immunization: Summary Tables

These summary tables are designed to assist program managers in developing optimal immunization schedules using key information from the World Health Organization (WHO). The first table summarizes recommended routine immunizations for all age …

Author: World Health Organization

Publication date: 2017

WHO Recommendations Regarding Vaccine Hesitancy

Vaccine hesitancy refers to delay in acceptance or refusal of safe vaccines despite availability of vaccination services. This special issue of Vaccine is guest-edited by the World Health Organization (WHO) and focuses on the topic of vaccine …

Author: Schuster M, Duclos P, eds.

Publication date: 2015

WHO Vaccine Reaction Rates Information Sheets

This web page provides links to information sheets on reaction rates of selected vaccines. The papers are primarily designed for use by national public health officials and immunization program managers. Data from these sheets can be used for the …

Author: World Health Organization

WHO/Health Canada Drafting Group Meeting on Scientific and Regulatory Considerations on the Stability Evaluation of Vaccines Under Controlled Temperature Chain

On December 4 to 6, 2012, a consultation was held under the auspices of the World Health Organization (WHO) and Health Canada in Ottawa to identify obstacles to further developing a controlled temperature chain for vaccines. As described in this …

Author: World Health Organization

Publication date: 2013

Page 89 of 90